@article {Williams2020.06.04.20121335, author = {Camille Mich{\`e}le Williams and Hugo Peyre and Roberto Toro and Anita Beggiato and Franck Ramus}, title = {Adjusting for Allometric Scaling in ABIDE I Challenges Subcortical Volume Differences in Autism Spectrum Disorder}, elocation-id = {2020.06.04.20121335}, year = {2020}, doi = {10.1101/2020.06.04.20121335}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {To properly adjust for total brain volume (TBV), brain allometry {\textendash} the non-linear scaling relationship between regional volumes and TBV {\textendash} was considered when examining subcortical volumetric differences between typically developing (TD) and Autistim Spectrum Disorder (ASD) individuals.Autism Brain Imaging Data Exchange I (N = 654) data was analyzed with two methodological approaches: univariate Linear Mixed Effects Models and multivariate Multiple Group Confirmatory Factor Analyses. Analyses were conducted on the entire sample and in subsamples based on age, sex, and Full Scale Intelligence Quotient (FSIQ). A similar ABIDE I study was replicated and the impact of different TBV adjustments on neuroanatomical group differences was investigated.No robust subcortical allometric or volumetric group differences were observed in the entire sample across methods. Exploratory analyses suggested that allometric scaling and volume group differences may exist in certain subgroups defined by age, sex, and/or FSIQ. The type of TBV adjustment influenced some reported volumetric and scaling group differences.This study supports the absence of robust volumetric differences between ASD and TD individuals in the investigated volumes when adjusting for brain allometry, expands the literature by finding no group difference in allometric scaling, and further suggests that differing TBV adjustments contribute to the variability of reported neuroanatomical differences in ASD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received support under the program Investissements d Avenir launched by the French Government and implemented by ANR with the references ANR-17-EURE-0017 and ANR-10-IDEX-0001-02 PSLAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data was anonymized and collected by studies approved by the regional Institutional Review Boards. Further details on participant recruitment and phenotypic and imaging data analyses are provided by Di Martino and colleagues (2014), https://doi.org/10.1038/mp.2013.78).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in Subcortical-Allometry-in-Autism at http://doi.org/10.5281/zenodo.3592884. http://doi.org/10.5281/zenodo.3592884}, URL = {https://www.medrxiv.org/content/early/2020/06/05/2020.06.04.20121335}, eprint = {https://www.medrxiv.org/content/early/2020/06/05/2020.06.04.20121335.full.pdf}, journal = {medRxiv} }